leadXpro AG

LeadXpro was founded in 2015 as a spin-out from the Paul Scherrer Institute (ETH) and is located between Zurich and Basel. The company aims to revolutionize the way drugs are being discovered for membrane proteins (e.g., GPCRs, ion channels, enzymes, transporters). These protein targets constitute more than half of the current drug targets but have not yet been fully amenable to structure-based drug design due to the considerable challenges in solving their atomic structures. To achieve our goal, we combine state-of-the-art methods for membrane protein science together with pioneering technologies in structural biology (Cryo-EM, XFEL). Our business model includes working...

Structure based drug discovery,membrane proteins,serial crystallography,cryo-electron microscopy,free electron laser,synchrotron,and biostructure

Leadxpro ag operates in the Biotechnology research industry.

Leadxpro ag's revenue is 11m - 100m

Leadxpro ag has 11 - 50 employees.